HEADER APOPTOSIS 05-MAR-07 2P1L TITLE STRUCTURE OF THE BCL-XL:BECLIN 1 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-X; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: BCL-XL DELTA-LOOP; COMPND 5 SYNONYM: BCL-XL; BCL-2-LIKE 1 PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BECLIN 1; COMPND 10 CHAIN: B, D, F, H; COMPND 11 FRAGMENT: BECLIN 1; COMPND 12 SYNONYM: COILED-COIL MYOSIN-LIKE BCL2-INTERACTING PROTEIN; PROTEIN COMPND 13 GT197; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSF; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: BECN1, GT197; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGEX-2T KEYWDS APOPTOSIS; AUTOPHAGY; BECLIN; BH3 DOMAIN; BCL, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR P.D.JEFFREY,Y.SHI,A.L.OBERSTEIN REVDAT 4 26-JUL-17 2P1L 1 SOURCE REMARK REVDAT 3 24-FEB-09 2P1L 1 VERSN REVDAT 2 05-JUN-07 2P1L 1 JRNL REVDAT 1 13-MAR-07 2P1L 0 JRNL AUTH A.OBERSTEIN,P.D.JEFFREY,Y.SHI JRNL TITL CRYSTAL STRUCTURE OF THE BCL-XL-BECLIN 1 PEPTIDE COMPLEX: JRNL TITL 2 BECLIN 1 IS A NOVEL BH3-ONLY PROTEIN JRNL REF J.BIOL.CHEM. V. 282 13123 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17337444 JRNL DOI 10.1074/JBC.M700492200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1611649.830 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 41260 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2107 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6487 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 360 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5284 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.03000 REMARK 3 B22 (A**2) : 19.33000 REMARK 3 B33 (A**2) : -13.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 36.97 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2P1L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000041852. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 3.990 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.41300 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% (W/V) PEG-400, 0.1M HEPES PH7.5, REMARK 280 0.2M SODIUM CITRATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 53.97000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.29500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.97000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.29500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: UNIQUE HETERODIMERIC COMPLEX IS FORMED BETWEEN CHAINS A AND REMARK 300 B, (BCL-XL AND BECLIN 1 RESPECTIVELY). A DIMER OF HETERODIMERS IS REMARK 300 FORMED BETWEEN THE A+B AND C+D COMPLEXES VIA A DOMAIN-SWAPPED REMARK 300 HELIX. THERE ARE TWO OF THESE "DIMERS OF HETERODIMERS" IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXADECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 38600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -258.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -110.59000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 -53.97000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 -55.29500 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 53.97000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 -55.29500 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 199 REMARK 465 ALA A 200 REMARK 465 ALA A 201 REMARK 465 GLU A 202 REMARK 465 SER A 203 REMARK 465 ARG A 204 REMARK 465 LYS A 205 REMARK 465 GLY A 206 REMARK 465 GLN A 207 REMARK 465 GLU A 208 REMARK 465 ARG A 209 REMARK 465 GLN B 129 REMARK 465 THR B 130 REMARK 465 ASP B 131 REMARK 465 VAL B 132 REMARK 465 ASP B 133 REMARK 465 HIS B 134 REMARK 465 PRO B 135 REMARK 465 MET C 1 REMARK 465 ALA C 199 REMARK 465 ALA C 200 REMARK 465 ALA C 201 REMARK 465 GLU C 202 REMARK 465 SER C 203 REMARK 465 ARG C 204 REMARK 465 LYS C 205 REMARK 465 GLY C 206 REMARK 465 GLN C 207 REMARK 465 GLU C 208 REMARK 465 ARG C 209 REMARK 465 GLN D 129 REMARK 465 THR D 130 REMARK 465 ASP D 131 REMARK 465 VAL D 132 REMARK 465 ASP D 133 REMARK 465 HIS D 134 REMARK 465 PRO D 135 REMARK 465 MET E 1 REMARK 465 ALA E 199 REMARK 465 ALA E 200 REMARK 465 ALA E 201 REMARK 465 GLU E 202 REMARK 465 SER E 203 REMARK 465 ARG E 204 REMARK 465 LYS E 205 REMARK 465 GLY E 206 REMARK 465 GLN E 207 REMARK 465 GLU E 208 REMARK 465 ARG E 209 REMARK 465 GLN F 129 REMARK 465 THR F 130 REMARK 465 ASP F 131 REMARK 465 VAL F 132 REMARK 465 ASP F 133 REMARK 465 HIS F 134 REMARK 465 PRO F 135 REMARK 465 MET G 1 REMARK 465 ALA G 199 REMARK 465 ALA G 200 REMARK 465 ALA G 201 REMARK 465 GLU G 202 REMARK 465 SER G 203 REMARK 465 ARG G 204 REMARK 465 LYS G 205 REMARK 465 GLY G 206 REMARK 465 GLN G 207 REMARK 465 GLU G 208 REMARK 465 ARG G 209 REMARK 465 GLN H 129 REMARK 465 THR H 130 REMARK 465 ASP H 131 REMARK 465 VAL H 132 REMARK 465 ASP H 133 REMARK 465 HIS H 134 REMARK 465 PRO H 135 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU G 174 CA - CB - CG ANGL. DEV. = 14.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 107 125.26 -2.28 REMARK 500 THR A 109 -97.00 -64.28 REMARK 500 GLN A 111 -57.90 -164.78 REMARK 500 ASP C 107 120.66 5.38 REMARK 500 THR C 109 -101.02 -63.25 REMARK 500 GLN C 111 -62.51 -159.99 REMARK 500 ASP C 133 40.14 -108.27 REMARK 500 GLN E 3 -76.27 -142.80 REMARK 500 SER E 4 100.53 -48.37 REMARK 500 ASP E 107 123.79 -1.28 REMARK 500 THR E 109 -94.46 -64.67 REMARK 500 GLN E 111 -67.20 -163.50 REMARK 500 ASP E 133 31.28 -99.09 REMARK 500 PHE G 105 -159.51 -125.07 REMARK 500 ASP G 107 120.38 7.87 REMARK 500 THR G 109 -93.89 -64.89 REMARK 500 GLN G 111 -64.81 -165.30 REMARK 500 ASP G 133 44.27 -100.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 2P1L A 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L C 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L E 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L G 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L A 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L C 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L E 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L G 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L B 107 135 UNP Q14457 BCN1_HUMAN 107 135 DBREF 2P1L D 107 135 UNP Q14457 BCN1_HUMAN 107 135 DBREF 2P1L F 107 135 UNP Q14457 BCN1_HUMAN 107 135 DBREF 2P1L H 107 135 UNP Q14457 BCN1_HUMAN 107 135 SEQADV 2P1L GLY B 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER B 106 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L GLY D 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER D 106 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L GLY F 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER F 106 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L GLY H 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER H 106 UNP Q14457 CLONING ARTIFACT SEQRES 1 A 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 A 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 A 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 A 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 A 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 A 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 A 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 A 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 A 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 A 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 A 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 A 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 B 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 B 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 B 31 ASP VAL ASP HIS PRO SEQRES 1 C 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 C 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 C 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 C 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 C 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 C 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 C 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 C 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 C 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 C 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 C 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 C 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 D 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 D 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 D 31 ASP VAL ASP HIS PRO SEQRES 1 E 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 E 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 E 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 E 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 E 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 E 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 E 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 E 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 E 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 E 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 E 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 E 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 F 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 F 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 F 31 ASP VAL ASP HIS PRO SEQRES 1 G 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 G 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 G 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 G 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 G 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 G 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 G 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 G 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 G 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 G 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 G 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 G 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 H 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 H 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 H 31 ASP VAL ASP HIS PRO FORMUL 9 HOH *16(H2 O) HELIX 1 1 SER A 2 GLN A 19 1 18 HELIX 2 2 SER A 25 ARG A 103 1 23 HELIX 3 3 THR A 115 PHE A 131 1 17 HELIX 4 4 ASN A 136 LYS A 157 1 22 HELIX 5 5 VAL A 161 LEU A 178 1 18 HELIX 6 6 LEU A 178 ASN A 185 1 8 HELIX 7 7 GLY A 186 GLY A 196 1 11 HELIX 8 8 SER B 106 MET B 126 1 21 HELIX 9 9 SER C 2 GLN C 19 1 18 HELIX 10 10 SER C 25 ARG C 103 1 23 HELIX 11 11 THR C 118 ARG C 132 1 15 HELIX 12 12 ASN C 136 LYS C 157 1 22 HELIX 13 13 VAL C 161 LEU C 178 1 18 HELIX 14 14 LEU C 178 ASN C 185 1 8 HELIX 15 15 GLY C 186 GLY C 196 1 11 HELIX 16 16 SER D 106 MET D 126 1 21 HELIX 17 17 SER E 4 GLN E 19 1 16 HELIX 18 18 SER E 25 ARG E 103 1 23 HELIX 19 19 THR E 118 PHE E 131 1 14 HELIX 20 20 ASN E 136 LYS E 157 1 22 HELIX 21 21 VAL E 161 LEU E 178 1 18 HELIX 22 22 LEU E 178 ASN E 185 1 8 HELIX 23 23 GLY E 186 GLY E 196 1 11 HELIX 24 24 SER F 106 MET F 126 1 21 HELIX 25 25 SER G 2 GLN G 19 1 18 HELIX 26 26 SER G 25 ARG G 103 1 23 HELIX 27 27 THR G 118 PHE G 131 1 14 HELIX 28 28 ASN G 136 LYS G 157 1 22 HELIX 29 29 GLN G 160 LEU G 178 1 19 HELIX 30 30 LEU G 178 ASN G 185 1 8 HELIX 31 31 GLY G 186 GLY G 196 1 11 HELIX 32 32 SER H 106 MET H 126 1 21 CRYST1 107.940 110.590 100.520 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009264 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009042 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009948 0.00000 MASTER 439 0 0 32 0 0 0 6 0 0 0 60 END